POMDOCTOR LTD - ADR

POMNASDAQ

🏆 #4333 by market capUS Equity

$1.03▼ $0.11 (−10.87%)

Market closed · at close

1h—

24h▼ 10.9%

7d▲ 48.1%

14d▲ 42.8%

30d▼ 33.2%

1y—

🏦Market Cap

$1M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

14.0%

Thin

💵FCF Margin

—

⚖️P/S Ratio

0.1x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $1.02 – $1.03
52-Week Range: —
Volume: $4.39B
Avg Volume: $4.78B
Shares Outstanding: 1.2M
Next Earnings: Oct 1, 2026

Fundamentals Snapshot

Annual Revenue: $400M
Last Q Revenue: $103M
P/E Ratio: —
P/S Ratio: 0.1x
EPS (TTM): —
Dividend Yield: —

Why Investors Own POM

✓High-growth profile — revenue up +43.0% YoY with expanding US Equity exposure.
✓Healthy economics — 44% gross margin and 30% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$400M▲ +39.5% YoY

Gross Margin (TTM)

43.8%▲ +4.2% YoY

Operating Income (TTM)

$107M▲ +39.5% YoY

Free Cash Flow (TTM)

$118M▲ +39.5% YoY

About POMDOCTOR LTD - ADR

Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.

🦦